In Brief: Allergan
Executive Summary
Allergan: Botox patient information leaflet cited by FDA in 1994 for off-label cosmetic promotions "was developed and used by an individual physician, and Allergan was not involved with its development or distribution," the company states. Allergan maintains that "it is the clearly enunciated policy of the company not to promote Botox for cosmetic or any other off-label use" ("The Pink Sheet" April 14, p. 17)...